Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...

Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Oklahoma City Thunder (9-1, first in the Western Conference) vs. Memphis Grizzlies (4-6, 10th in the Western Conference)Memphis, Tennessee; Sunday, 6 ...

While delegates at a U.N. conference discussed how to fulfill past promises on fighting climate change, a boisterous ...

Aurora Cannabis (US) (($TSE:ACB)) has held its Q2 earnings call. Read on for the main highlights of the call. Aurora Cannabis Earnings Call ...

Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued ...

Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net Revenue 1 by 22% to Record ...

Aurora Cannabis ( ($TSE:ACB) ) has shared an announcement. Aurora Cannabis reported its fiscal 2026 second quarter results, showcasing a 15% ...